DA

Dr. Ananya Sharma

CSO

Aurigene Pharmaceutical Services

Therapeutic Areas

Aurigene Pharmaceutical Services Pipeline

DrugIndicationPhase
AUR-101Triple‑negative breast cancer and solid tumorsPreclinical
AUR-102MYC‑driven cancersPreclinical
AUR-103B‑cell malignanciesPreclinical

Leadership Team at Aurigene Pharmaceutical Services

View full Aurigene Pharmaceutical Services profile